Cite Filings / KLRA
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)

CIK 0002096997

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Kailera Therapeutics, Inc.

Sign in to watch
Ticker
KLRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 508-440-9475
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA, 02451
Filings Financials Insiders Search text
All 64 Financials 7 Executive Compensation 4 Insider Trading 42 Beneficial Ownership Interest 5 Business Combinations 4 Public Offerings 3 Others 7
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-14
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-14
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-05
  5. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-04-23
  6. SCHEDULE 13D Stake ● Beneficial Ownership Report 2026-04-23

Page 1 of 1 · 5 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…